120 related articles for article (PubMed ID: 11045468)
21. Ecteinascidin-743.
Held-Warmkessel J
Clin J Oncol Nurs; 2003; 7(3):313-9. PubMed ID: 12793338
[TBL] [Abstract][Full Text] [Related]
22. DNA structural similarity in the 2:1 complexes of the antitumor drugs trabectedin (Yondelis) and chromomycin A3 with an oligonucleotide sequence containing two adjacent TGG binding sites on opposing strands.
Marco E; Gago F
Mol Pharmacol; 2005 Dec; 68(6):1559-67. PubMed ID: 16150929
[TBL] [Abstract][Full Text] [Related]
23. The antitumor agent ecteinascidin 743: characterization of its covalent DNA adducts and chemical stability.
Hurley LH; Zewail-Foote M
Adv Exp Med Biol; 2001; 500():289-99. PubMed ID: 11764956
[TBL] [Abstract][Full Text] [Related]
24. Recent synthetic approaches to 6,15-iminoisoquino[3,2-b]3-benzazocine compounds.
Avendaño C; de la Cuesta E
Chemistry; 2010 Aug; 16(32):9722-34. PubMed ID: 20533463
[TBL] [Abstract][Full Text] [Related]
25. DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata.
Pommier Y; Kohlhagen G; Bailly C; Waring M; Mazumder A; Kohn KW
Biochemistry; 1996 Oct; 35(41):13303-9. PubMed ID: 8873596
[TBL] [Abstract][Full Text] [Related]
26. A 3.(ET743)-DNA complex that both resembles an RNA-DNA hybrid and mimicks zinc finger-induced DNA structural distortions.
Marco E; García-Nieto R; Mendieta J; Manzanares I; Cuevas C; Gago F
J Med Chem; 2002 Feb; 45(4):871-80. PubMed ID: 11831898
[TBL] [Abstract][Full Text] [Related]
27. DNA and non-DNA targets in the mechanism of action of the antitumor drug trabectedin.
David-Cordonnier MH; Gajate C; Olmea O; Laine W; de la Iglesia-Vicente J; Perez C; Cuevas C; Otero G; Manzanares I; Bailly C; Mollinedo F
Chem Biol; 2005 Nov; 12(11):1201-10. PubMed ID: 16298299
[TBL] [Abstract][Full Text] [Related]
28. Chemistry of renieramycins. Part 4.synthesis of a simple natural marine product, 6-hydroxy-7-methoxyisoquinolinemethanol.
Saito N; Tanaka C; Satomi T; Oyama C; Kubo A
Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):282-6. PubMed ID: 14758020
[TBL] [Abstract][Full Text] [Related]
29. Dual inhibition of ATR and ATM potentiates the activity of trabectedin and lurbinectedin by perturbing the DNA damage response and homologous recombination repair.
Lima M; Bouzid H; Soares DG; Selle F; Morel C; Galmarini CM; Henriques JA; Larsen AK; Escargueil AE
Oncotarget; 2016 May; 7(18):25885-901. PubMed ID: 27029031
[TBL] [Abstract][Full Text] [Related]
30. Synthetic studies on Et-743. Assembly of the pentacyclic core and a formal total synthesis.
Fishlock D; Williams RM
J Org Chem; 2008 Dec; 73(24):9594-600. PubMed ID: 18687003
[TBL] [Abstract][Full Text] [Related]
31. Chemistry of Ecteinascidins. Part 5: An Additional Proof of Cytotoxicity Evaluation of Ecteinascidin 770 Derivatives.
Toyoshima R; Mori N; Suzuki T; Lowtangkitcharoen W; Suwanborirux K; Saito N
Chem Pharm Bull (Tokyo); 2016; 64(7):966-9. PubMed ID: 27373655
[TBL] [Abstract][Full Text] [Related]
32. New drugs from the sea.
D'Incalci M; Simone M; Tavecchio M; Damia G; Garbi A; Erba E
J Chemother; 2004 Nov; 16 Suppl 4():86-9. PubMed ID: 15688619
[TBL] [Abstract][Full Text] [Related]
33. Total Synthesis of Lamellarin D Trimethyl Ether, Lamellarin D, and Lamellarin H.
Lade DM; Pawar AB; Mainkar PS; Chandrasekhar S
J Org Chem; 2017 May; 82(9):4998-5004. PubMed ID: 28421766
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of natural ecteinascidins (ET-729, ET-745, ET-759B, ET-736, ET-637, ET-594) from cyanosafracin B.
Menchaca R; Martínez V; Rodríguez A; Rodríguez N; Flores M; Gallego P; Manzanares I; Cuevas C
J Org Chem; 2003 Nov; 68(23):8859-66. PubMed ID: 14604355
[TBL] [Abstract][Full Text] [Related]
35. A general catalytic route to isoindolinones and tetrahydroisoquinolines: application in the synthesis of (±)-crispine A.
Dhanasekaran S; Bisai V; Unhale RA; Suneja A; Singh VK
Org Lett; 2014 Dec; 16(23):6068-71. PubMed ID: 25393501
[TBL] [Abstract][Full Text] [Related]
36. Structure elucidation and 1H/13C NMR spectral assignments of four trabectedin related compounds.
Vermeulen W; Filliers W; García C; Manzanaro S; Montalvo D; Polanco C; Spillemaeckers F; Van Hoof B; Winderickx G; Somers I; Rodriguez-Campos I
Magn Reson Chem; 2008 Dec; 46(12):1198-202. PubMed ID: 18821578
[TBL] [Abstract][Full Text] [Related]
37. ET-743 (PharmaMar/NCI/Ortho Biotech).
Verschraegen CF; Glover K
Curr Opin Investig Drugs; 2001 Nov; 2(11):1631-8. PubMed ID: 11763168
[TBL] [Abstract][Full Text] [Related]
38. Trabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766.
Drugs R D; 2006; 7(5):317-28. PubMed ID: 16922593
[TBL] [Abstract][Full Text] [Related]
39. Characterisation of antimitotic products from marine organisms that disorganise the microtubule network: ecteinascidin 743, isohomohalichondrin-B and LL-15.
García-Rocha M; García-Gravalos MD; Avila J
Br J Cancer; 1996 Apr; 73(8):875-83. PubMed ID: 8611420
[TBL] [Abstract][Full Text] [Related]
40. Direct C-H Allylation of N-Acyl/Sulfonyl Tetrahydroisoquinolines and Analogues.
Yan C; Liu Y; Wang Q
Org Lett; 2015 Nov; 17(22):5714-7. PubMed ID: 26558601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
